Clinical trial Recruiting at 3 sites Observational Ages 1 Day to 99

Copenhagen Baby Heart Study - Impact

Run by Copenhagen University Hospital, Rigshospitalet · NCT05838079 · Data updated 2026-11-12

This study looks at how common undetected heart problems are in newborns and their effects during early childhood, while also checking heart health in Danish kids.

Quick facts

Study typeObservational
Ages1 Day to 99 Years
SexAll
Enrollment35000 (estimated)
SponsorCopenhagen University Hospital, Rigshospitalet
Academic / other
Locations3 sites (Copenhagen Ø and 2 other locations)
StatusRecruiting
StartedNovember 1, 2018
Main results expectedJuly 2029
Study endsJuly 2029
Registry record updatedMay 1, 2023
Trial IDNCT05838079 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include newborns who participated in the original Copenhagen Baby Heart study or their family members, as well as children born to mothers with pre-existing or gestational diabetes.

Probably not a fit

Patients who do not have a connection to the original study or do not meet the specific inclusion criteria may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Copenhagen Baby Heart Study - Impact (CBHS-I) is an observational study that extends the previous Copenhagen Baby Heart study, which involved over 25,000 newborns in the Copenhagen area. This study aims to assess the prevalence of congenital and inherited heart diseases that were not detected prenatally and to evaluate their consequences during early childhood. Participants will undergo clinical examinations, including echocardiography and electrocardiography, to establish reference values for these tests in Danish children. Additionally, the study will explore associations between various prenatal and postnatal factors and the risk of congenital heart disease.

Why it matters

Potential benefit: If successful, this study could lead to improved early detection and management of congenital heart diseases in children.

How similar studies have gone: Other studies focusing on congenital heart disease have shown success in identifying risk factors and improving outcomes, making this approach promising.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participant in CBH or
* Family member of a participant in CBH or
* Born to mothers with pre-existing or gestational diabetes at either Rigshospitalet, Hvidovre Hospital, or Herlev Hospital during the period July 2020 through December 2023.

Exclusion Criteria:

* Faliure of providing concent (parents)

Where it's running

  • Rigshospitalet Copenhagen University Hospital.
    Copenhagen Ø, Denmark
    Recruiting
  • Herlev and Gentofte Hospital
    Herlev, Denmark
    Recruiting
  • Hvidovre Hospital
    Hvidovre, Denmark
    Recruiting

Study contacts

  • Principal investigator: Henning Bundgaard, MD, DMSc — Department of Cardiology, The Heart Center, Rigshospitalet, Copenhagen University Hospital, Denmark
  • Study coordinator: Henning Bundgaard, MD, DMSc
  • Email: henning.bundgaard@regionh.dk
  • Phone: +4535450512

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.